newsfilter
← Latest News
GlobeNewswire·

AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19

- Meeting date aligns with prior guidance - - FDA to review AEON's analytical development plan and initial data - IRVINE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. ("AEON" or the "Company")